695 related articles for article (PubMed ID: 26061544)
1. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
2. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
3. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.
Vuong MT; Hahn-Zoric M; Lundberg S; Gunnarsson I; van Kooten C; Wramner L; Seddighzadeh M; Fernström A; Hanson LÅ; Do LT; Jacobson SH; Padyukov L
Kidney Int; 2010 Dec; 78(12):1281-7. PubMed ID: 20811333
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation.
Berthoux F; Suzuki H; Mohey H; Maillard N; Mariat C; Novak J; Julian BA
J Am Soc Nephrol; 2017 Jun; 28(6):1943-1950. PubMed ID: 28255003
[TBL] [Abstract][Full Text] [Related]
5. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
[TBL] [Abstract][Full Text] [Related]
6. Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History.
Wu H; Wang X; Yang Z; Zhao Q; Wen Y; Li X; Zhang W; Gao R
Dis Markers; 2020; 2020():8393075. PubMed ID: 32076466
[TBL] [Abstract][Full Text] [Related]
7. Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case.
Cambier A; Dossier C; Hogan J; Baudouin V; Maisin A; Couderc A; Kwon T; Gleeson PJ; Monteiro RC
Pediatr Nephrol; 2022 Jul; 37(7):1597-1603. PubMed ID: 34997322
[TBL] [Abstract][Full Text] [Related]
8. Circulating CD89-IgA complex does not predict deterioration of kidney function in Korean patients with IgA nephropathy.
Jhee JH; Kang HY; Wu M; Nam BY; Chang TI; Jung SY; Park S; Kim H; Yun HR; Kee YK; Yoon CY; Park JT; Yoo TH; Kang SW; Han SH
Clin Chem Lab Med; 2017 Nov; 56(1):75-85. PubMed ID: 28672768
[TBL] [Abstract][Full Text] [Related]
9. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
[TBL] [Abstract][Full Text] [Related]
10. Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
Maixnerova D; Ling C; Hall S; Reily C; Brown R; Neprasova M; Suchanek M; Honsova E; Zima T; Novak J; Tesar V
PLoS One; 2019; 14(2):e0212254. PubMed ID: 30794576
[TBL] [Abstract][Full Text] [Related]
11. Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy.
van der Boog PJ; De Fijter JW; Van Kooten C; Van Der Holst R; Van Seggelen A; Van Es LA; Daha MR
Kidney Int; 2003 Feb; 63(2):514-21. PubMed ID: 12631116
[TBL] [Abstract][Full Text] [Related]
12. Post-transplant immunoglobulin A deposition and nephropathy in allografts.
Sofue T; Suzuki H; Ueda N; Kushida Y; Minamino T
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():4-9. PubMed ID: 29968406
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.
Berthoux F; Suzuki H; Thibaudin L; Yanagawa H; Maillard N; Mariat C; Tomino Y; Julian BA; Novak J
J Am Soc Nephrol; 2012 Sep; 23(9):1579-87. PubMed ID: 22904352
[TBL] [Abstract][Full Text] [Related]
14. A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy.
Temurhan S; Akgul SU; Caliskan Y; Artan AS; Kekik C; Yazici H; Demir E; Caliskan B; Turkmen A; Oguz FS; Sever MS
Transplant Proc; 2017 Apr; 49(3):541-545. PubMed ID: 28340830
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys.
Taylor S; Pieri K; Nanni P; Tica J; Barratt J; Didangelos A
J Autoimmun; 2019 Dec; 105():102309. PubMed ID: 31402200
[TBL] [Abstract][Full Text] [Related]
16. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
Placzek WJ; Yanagawa H; Makita Y; Renfrow MB; Julian BA; Rizk DV; Suzuki Y; Novak J; Suzuki H
PLoS One; 2018; 13(1):e0190967. PubMed ID: 29324897
[TBL] [Abstract][Full Text] [Related]
17. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression.
Zhao N; Hou P; Lv J; Moldoveanu Z; Li Y; Kiryluk K; Gharavi AG; Novak J; Zhang H
Kidney Int; 2012 Oct; 82(7):790-6. PubMed ID: 22673888
[TBL] [Abstract][Full Text] [Related]
18. Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation.
Kawabe M; Yamamoto I
Nephron; 2023; 147 Suppl 1():9-13. PubMed ID: 36966530
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors.
Berthelot L; Papista C; Maciel TT; Biarnes-Pelicot M; Tissandie E; Wang PH; Tamouza H; Jamin A; Bex-Coudrat J; Gestin A; Boumediene A; Arcos-Fajardo M; England P; Pillebout E; Walker F; Daugas E; Vrtosvnik F; Flamant M; Benhamou M; Cogné M; Moura IC; Monteiro RC
J Exp Med; 2012 Apr; 209(4):793-806. PubMed ID: 22451718
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
Cambier A; Gleeson PJ; Abbad L; Canesi F; da Silva J; Bex-Coudrat J; Deschênes G; Boyer O; Rabant M; Ulinski T; Hogan J; Peuchmaur M; Berthelot L; Monteiro RC
Kidney Int; 2022 Feb; 101(2):274-287. PubMed ID: 34756952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
